Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

H. J. Meulenbeld, E. D. Van Werkhoven, J. L.L.M. Coenen, G. J. Creemers, O. J.L. Loosveld, P. C. De Jong, A. J. Ten Tije, S. D. Fosså, M. Polee, W. Gerritsen, O. Dalesio, R. De Wit

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)'. Together they form a unique fingerprint.

Medicine & Life Sciences